Skip to content
Screener

MBX Biosciences, Inc. MBX Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.48B+20.2%
Amgen logo
AmgenAMGN
$12.98B+17.7%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$33K-28.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.12M+11.1%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$7.98M+25.9%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$2.52M-64.8%

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$3.19B+719%
Enterprise value$3.15B+798%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 9:03 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-210593
Line itemMarch 31, 2026December 31, 2025
Total current assets448,536381,539
Property and equipment, net3,1332,735
Right-of-use assets453487
Other assets579383
Total assets$452,701$385,144
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$6,974$2,977

Item 1. Financial Statements.

FAQ

What is MBX Biosciences, Inc.'s other non-current assets?
MBX Biosciences, Inc. (MBX) reported other non-current assets of $579K in Q1 2026.
How has MBX Biosciences, Inc.'s other non-current assets changed year-over-year?
MBX Biosciences, Inc.'s other non-current assets increased by 1058.0% year-over-year, from $50K to $579K.
What is the long-term trend for MBX Biosciences, Inc.'s other non-current assets?
Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s other non-current assets has grown at a 176.8% compound annual growth rate (CAGR), from $50K to $383K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about MBX Biosciences, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude